Utility of measuring (1,3)-β-D-Glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection

Jennifer L. Lyons, Kiran T. Thakur, Rick Lee, Tonya Watkins, Carlos A. Pardo, Kathryn A. Carson, Barbara Markley, Malcolm A. Finkelman, Kieren A. Marr, Karen Roos, Sean X. Zhang

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

(1-3)-β-D-Glucan (BDG) from cerebrospinal fluid (CSF) is a promising marker for diagnostic and prognostic aid of central nervous system (CNS) fungal infection, but its relationship to serum values has not been studied. Herein, we detected BDG from CSF at levels 2-fold lower than those in serum in patients without evidence of fungal disease but 25-fold higher than those in in serum in noncryptococcal CNS fungal infections. CSF BDG may be a useful biomarker in the evaluation of fungal CNS disease.

Original languageEnglish
Pages (from-to)319-322
Number of pages4
JournalJournal of Clinical Microbiology
Volume53
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Central Nervous System Fungal Infections
Cerebrospinal Fluid
Serum
Mycoses
Central Nervous System Diseases
Biomarkers
polyglucosan

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Lyons, J. L., Thakur, K. T., Lee, R., Watkins, T., Pardo, C. A., Carson, K. A., ... Zhang, S. X. (2015). Utility of measuring (1,3)-β-D-Glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection. Journal of Clinical Microbiology, 53(1), 319-322. https://doi.org/10.1128/JCM.02301-14

Utility of measuring (1,3)-β-D-Glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection. / Lyons, Jennifer L.; Thakur, Kiran T.; Lee, Rick; Watkins, Tonya; Pardo, Carlos A.; Carson, Kathryn A.; Markley, Barbara; Finkelman, Malcolm A.; Marr, Kieren A.; Roos, Karen; Zhang, Sean X.

In: Journal of Clinical Microbiology, Vol. 53, No. 1, 01.01.2015, p. 319-322.

Research output: Contribution to journalArticle

Lyons, JL, Thakur, KT, Lee, R, Watkins, T, Pardo, CA, Carson, KA, Markley, B, Finkelman, MA, Marr, KA, Roos, K & Zhang, SX 2015, 'Utility of measuring (1,3)-β-D-Glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection', Journal of Clinical Microbiology, vol. 53, no. 1, pp. 319-322. https://doi.org/10.1128/JCM.02301-14
Lyons, Jennifer L. ; Thakur, Kiran T. ; Lee, Rick ; Watkins, Tonya ; Pardo, Carlos A. ; Carson, Kathryn A. ; Markley, Barbara ; Finkelman, Malcolm A. ; Marr, Kieren A. ; Roos, Karen ; Zhang, Sean X. / Utility of measuring (1,3)-β-D-Glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection. In: Journal of Clinical Microbiology. 2015 ; Vol. 53, No. 1. pp. 319-322.
@article{76ca5c9c8d2449a0af4abbb9dacf7892,
title = "Utility of measuring (1,3)-β-D-Glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection",
abstract = "(1-3)-β-D-Glucan (BDG) from cerebrospinal fluid (CSF) is a promising marker for diagnostic and prognostic aid of central nervous system (CNS) fungal infection, but its relationship to serum values has not been studied. Herein, we detected BDG from CSF at levels 2-fold lower than those in serum in patients without evidence of fungal disease but 25-fold higher than those in in serum in noncryptococcal CNS fungal infections. CSF BDG may be a useful biomarker in the evaluation of fungal CNS disease.",
author = "Lyons, {Jennifer L.} and Thakur, {Kiran T.} and Rick Lee and Tonya Watkins and Pardo, {Carlos A.} and Carson, {Kathryn A.} and Barbara Markley and Finkelman, {Malcolm A.} and Marr, {Kieren A.} and Karen Roos and Zhang, {Sean X.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1128/JCM.02301-14",
language = "English",
volume = "53",
pages = "319--322",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Utility of measuring (1,3)-β-D-Glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection

AU - Lyons, Jennifer L.

AU - Thakur, Kiran T.

AU - Lee, Rick

AU - Watkins, Tonya

AU - Pardo, Carlos A.

AU - Carson, Kathryn A.

AU - Markley, Barbara

AU - Finkelman, Malcolm A.

AU - Marr, Kieren A.

AU - Roos, Karen

AU - Zhang, Sean X.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - (1-3)-β-D-Glucan (BDG) from cerebrospinal fluid (CSF) is a promising marker for diagnostic and prognostic aid of central nervous system (CNS) fungal infection, but its relationship to serum values has not been studied. Herein, we detected BDG from CSF at levels 2-fold lower than those in serum in patients without evidence of fungal disease but 25-fold higher than those in in serum in noncryptococcal CNS fungal infections. CSF BDG may be a useful biomarker in the evaluation of fungal CNS disease.

AB - (1-3)-β-D-Glucan (BDG) from cerebrospinal fluid (CSF) is a promising marker for diagnostic and prognostic aid of central nervous system (CNS) fungal infection, but its relationship to serum values has not been studied. Herein, we detected BDG from CSF at levels 2-fold lower than those in serum in patients without evidence of fungal disease but 25-fold higher than those in in serum in noncryptococcal CNS fungal infections. CSF BDG may be a useful biomarker in the evaluation of fungal CNS disease.

UR - http://www.scopus.com/inward/record.url?scp=84919472872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919472872&partnerID=8YFLogxK

U2 - 10.1128/JCM.02301-14

DO - 10.1128/JCM.02301-14

M3 - Article

VL - 53

SP - 319

EP - 322

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 1

ER -